Stroke is a focal neurological syndrome of
vascular basis, which may be due to ischemic thrombo-embolism or intra-cerebral
haemorrhage. This condition has to be
treated on emergency basis as it may cause an irreversible neurological damage.
Warfarin has been a widely used oral anti-coagulant in treating ischemic stroke
patients. This review highlights the
benefits and challenges of warfarin treatment in stroke patients and discusses
about the importance of risk stratification scores & bleeding scores in
estimating the bleeding risk associated with warfarin treatment. This review
also highlights the use of stroke outcome measures in identifying the patients
with post-stroke disabilities to provide patient specific treatment.
Credits: Srikanth Kaithoju